• Sofia Ioannidou joined Andera Partners’ BioDiscovery team in 2009 as an Associate. She was promoted to Partner in 2019.
  • Prior to Andera Partners, Sofia was part of the Life Sciences team of L.E.K. Consulting London, from 2006 to 2008, having started her career in R&D with Boston-based Eyetech Pharmaceuticals, Inc., from 2003 to 2006.
  • Since 2009, she has actively contributed to a number of investments, trade sales and IPOs. Sofia currently serves on the board of Tricares, Avalyn, Exciva and PegaOne and has previously served on the boards of LogicBio and Sanifit.
  • She holds a PhD in Cell Biology from Cancer Research UK and an MBiochem from the University of Oxford.
  • Sofia is a native Greek speaker and also speaks English, French and Spanish.

4 languages spoken